Daiichi Sankyo (Germany)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (Germany), Germany, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
52%
Total
Publications
1.3K
Total Open
Publications
674
Total
Citations
35K
Open Access
Percentage
52%
Total
Publications
1.3K
Total Open
Publications
674
Total
Citations
35K
Breakdown
Publisher Open
32%
Both
16%
Other Platform Open
4%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
150
Hybrid 20%
127
No Guarantees 56%
345
Other Platform Open
Domain 72%
193
Institution 26%
70
Other Internet 17%
46
Preprint 5%
13
Public 1%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 194 |
DOI | Other Internet | 44 |
Royal Netherlands Academy of Arts and Sciences | Institution | 25 |
King's College London | Institution | 15 |
Research Square | Preprint | 12 |
Europe PMC | Domain | 9 |
University of Modena and Reggio Emilia | Institution | 7 |
universiteitleiden.nl OAI-PMH Repository | Institution | 6 |
University of Pisa | Institution | 5 |
Hasselt University | Institution | 4 |